These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 822295)

  • 1. [Treatment of sound perception deafness with Danaden retard].
    Koeppel FW
    MMW Munch Med Wochenschr; 1976 Aug; 118(32-33):1015-6. PubMed ID: 822295
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
    Engelmann G
    Med Welt; 1975 Jul; 26(29-30):1380-4. PubMed ID: 1100984
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurophysiologic control during treatment of cerebral ischaemia with danaden retard (author's transl)].
    Klensch H; Hoffmann HR
    Med Klin; 1975 Jun; 70(26):1133-8. PubMed ID: 1223617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia].
    Kleiber G; Leickert KH
    ZFA (Stuttgart); 1979 Jul; 55(21):1199-205. PubMed ID: 157647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index].
    Bossini A; Pirro C; Barba C
    Clin Ter; 1984 Sep; 110(5):417-28. PubMed ID: 6238757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic activity of a combination of nicotinyl alcohol, vitamin A and vitamin E in atherosclerotic arteriopathies].
    Putignano G
    Clin Ter; 1980 Aug; 94(3):275-82. PubMed ID: 7449347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of a retard preparation of beta-pyridylcarbinol using a new automated assay method].
    Schräpler P; Schulz E; Scholer A
    Med Welt; 1977 Nov; 28(46):1900-3. PubMed ID: 593135
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of hypertriglyceridemia].
    Wollenweber J
    ZFA (Stuttgart); 1978 Feb; 54(6):349-53. PubMed ID: 636529
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
    Fodor GP
    ZFA (Stuttgart); 1978 Jan; 54(1):49-55. PubMed ID: 622856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of lipolytic and inotropic stimulation on myocardial ischemic injury.
    Kjekshus JK
    Acta Med Scand Suppl; 1976; 587():35-42. PubMed ID: 1062131
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood levels and effectiveness of beta-pyridyl carbinol in a new controlled release form in subjects with healthy metabolism and in patients with hyperlipoproteinemia II].
    Schulz E; Schräpler P
    Ther Umsch; 1980 Feb; 37(2):137-43. PubMed ID: 7385082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful treatment of rheumatoid arthritis with pyrithioxin (Enerbol, Polfa)].
    Brühl W; Cygler B
    Reumatologia; 1979; 17(3):337-8. PubMed ID: 515579
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Piracetam and pyrithioxine.
    Leary PM; Arens LJ; Rabkin J
    S Afr Med J; 1975 Jul; 49(31):1236. PubMed ID: 1154186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pyrithioxin in the treatment of patients with rheumatoid arthritis (comparative study with D-penicillamine)].
    Tosković B
    Reumatizam; 1983; 30(3):60-8. PubMed ID: 6351211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with Vertigo-Vomex retard in the treatment of vertigo and tinnitus].
    Wilms R
    Med Welt; 1975 Apr; 26(16):785-7. PubMed ID: 1100977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of senile hearing impairment with SP 54 in double-blind experiment].
    Mŭller E
    Med Welt; 1975 Mar; 26(12):574-5. PubMed ID: 1134298
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sulfhydryl-based treatment of rheumatoid arthritis (penicillamine, pyrithioxin, thiopronine)].
    Camus JP; Prier A; Cassou B; Bergevin H
    Rev Prat; 1980 Apr; 30(23):1517-8, 1521-3. PubMed ID: 7384712
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and immunological effects of treatment of rheumatoid arthritis with pyrithioxin (Enerbol Polfa)].
    Brühl W; Swierczyńska Z; Szymańska-Cygler B; Dyznarowska H; Chrzczonowski Z; Loth E; Zabek J
    Reumatologia; 1980; 18(3):241-8. PubMed ID: 6448464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].
    Dubiel JP; Cibor E; Bieron K; Zmuda A; Kostka-Trabka E
    Kardiol Pol; 1988; 31(10):626-32. PubMed ID: 3253452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.